Ministry of Chemicals and Fertilizers notifies ceiling price of certain scheduled formulations

Ministry of Chemicals and Fertilizers notifies ceiling price of certain scheduled formulations

October 13, 2017 Industry Specific 0

Through an order dated 20th September, 2017 issued under the Drugs (Prices Control) Order, 2013 (“DPCO, 2013”), the Ministry of Chemicals and Fertilizers (“Ministry”) has fixed and notified the ceiling prices, (exclusive of Goods and Services Tax) of scheduled formulations specified below:


Sl. No.Name of the Scheduled FormulationDosage form & StrengthUnitCeiling Price


RifabutinCapsule 150mg1 Capsule35.99
FluconazoleOral Liquid 50mg/5ml1 ML2.28
SumatriptanTablet 25mg1 Tablet30.21
SumatriptanTablet 50mg1 Tablet46.76
IohexolInjection 300mg iodine/ml1 ML15.08
Hepatitis B immunoglobulin Each Pack4998.20
IsoniazidTablet 300mg1 Tablet1.08
IsoniazidTablet 100mg1 Tablet0.62
Actinomycin DPowder for Injection 0.5mgEach Pack287.76
IfosfamidePowder for Injection 1gEach Pack328.33
VinblastineInjection 1mg/ml1 ML18.62
Silver SulphadiazineCream 1%1 GM0.27
Measles vaccineVaccineEach Pack (0.5ml)46.27
CloxacillinPowder for Injection250mgEach Pack4.03
GriseofulvinTablet 125mg1 Tablet0.74
Diloxanide furoateTablet 500mg1 Tablet0.96
GlycerinOral Liquid1 ML0.13599
ChlorhexidineSolution 5% (Concentrate for dilution)1 ML0.14194
Hydrogen peroxideSolution 6%1 ML0.03634
MannitolInjection 10%1 ML0.14626
DicyclomineTablet 10mg1 Tablet0.09955
Anti-tetanus immunoglobulin Each Pack748.06
Diphtheria antitoxin10000 IUEach Pack1189.22
PyridoxineTablet 10mg1 Tablet0.10491
Vitamin ACapsule 50000 IU1 Capsule0.50
Ascorbic Acid (Vitamin C)Tablet 100mg1 Tablet0.17603
Artesunate (A) + Sulphadoxine – Pyrimethamine (B)Tablet 100 mg (A) + 1 Tablet (750 mg + 37.5 mg) (B)Combi pack26.77
Artesunate (A) + Sulphadoxine – Pyrimethamine (B)Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B)Combi pack36.34
Artesunate (A) + Sulphadoxine – Pyrimethamine (B)Tablet 200 mg (A) + 2 Tablet (750 mg + 37.5 mg) (B)Combi pack33.13
Artesunate (A) + Sulphadoxine – Pyrimethamine (B)Tablet 25 mg (A) + 1 Tablet (250 mg + 12.5 mg) (B)Combi pack17.84
Acetylsalicylic acidTablet 350mg1 Tablet0.28
Ferrous salt (A) + Folic acid (B)Oral liqiud 20mg elemental iron (A) + 100mcg (B)/ml1 ML0.12074
Ferrous salt (A) + Folic acid (B)Tablet 100 mg elemental iron (A) + 500 mcg (B)1 Tablet0.09821
Ferrous salt (A) + Folic acid (B)Tablet 45mg elemental iron (A) + 400 mcg (B)1 Tablet0.12755
White PetrolatumJelly 100%1 GM0.0843
DicyclomineOral Solution 10mg/5ml1 ML0.15089
Vitamin AOral liquid 100000 IU/ml1 ML0.47
Rabies Human Monoclonal Antibody (rDNA) (Rabishield)Rabies Human Monoclonal Antibody 100IU/2.5ml

Each ml contains: Rabies Human Monoclonal Antibody (rDNA) 40IU

Each Pack8,055.68
Rabies Human Monoclonal Antibody (rDNA) (Rabishield)Rabies Human Monoclonal Antibody 250IU/2.5ml

Each ml contains: Rabies Human Monoclonal Antibody (rDNA) 100IU

Each Pack20,139.20


Key Features:

  • All manufacturers of scheduled formulations, selling branded or generic or both versions of scheduled formulations at a price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, have been mandated to revise the prices of all such formulations downward not exceeding the ceiling price as specified in the Column “Ceiling Price” in the table above.


  • All the existing manufacturers of above mentioned scheduled formulations, having MRP lower than the ceiling price specified in column “Ceiling Price” in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with DPCO, 2013.


  • After notification of the ceiling price, the manufacturer must issue a price list in Form–V to the National Pharmaceutical Pricing Authority (“NPPA”) through Integrated Pharmaceutical Database Management System (“IPDMS”) Portal and submit a copy to State Drug Controller and dealers.


  • Every retailer and dealer must display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business so that it is easily accessible to any person wishing to consult the same.


  • The manufacturers of the above mentioned scheduled formulations must furnish quarterly return to the NPPA through the IPDMS Portal for production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013.


  • The manufacturers not complying with the ceiling price specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the DPCO, 2013 read with Essential Commodities Act, 1955.



Source: Ministry of Chemicals and Fertilizers

About the author



Would you like to share your thoughts?

Your email address will not be published. Required fields are marked *

Leave a Reply